Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-17 3:10 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Consonance Capital Management LP | 4,703,435 9.99% | -1,355,070 (-22.37%) | View |
| 2021-02-17 3:09 pm Purchase | 13G | CASI PHARMACEUTICALS INC CASI | Consonance Capital Management LP | 7,576,431 6.11% | 1,517,926 (+25.05%) | View |
| 2021-02-17 3:08 pm Sale | 13G | AXOGEN, INC. AXGN | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:07 pm Sale | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Consonance Capital Management LP | 1,969,875 5.97% | -4,088,630 (-67.49%) | View |
| 2021-02-17 3:05 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:05 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-17 2:23 pm Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Consonance Capital Management LP | 2,729,709 6.38% | -3,328,796 (-54.94%) | View |
| 2021-02-17 2:22 pm Sale | 13G | AURINIA PHARMACEUTICALS INC AUPH | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-17 2:22 pm Sale | 13G | OMEROS CORPORATION OMER | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-17 2:21 pm Sale | 13G | CAREDX INC CDNA | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-16 4:27 pm Unchanged | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 6,058,505 9.99% | 0 (Unchanged) | View |
| 2021-02-16 4:19 pm Purchase | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 6,058,505 11% | 6,058,505 (New Position) | View |
| 2021-02-16 4:18 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Consonance Capital Management LP | 6,058,505 9.99% | 4,088,630 (+207.56%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 6,058,505 11% | 6,058,505 (New Position) | View |
| 2021-02-16 2:40 pm Purchase | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
| 2021-02-16 2:40 pm Sale | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 0 0% | -2,314,421 (Position Closed) | View |
| 2021-02-16 2:39 pm Sale | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 0 0% | -2,363,724 (Position Closed) | View |
| 2021-02-16 2:38 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Consonance Capital Management LP | 1,969,875 5.97% | 91,480 (+4.87%) | View |
| 2021-02-16 2:37 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 0 0% | -4,772,190 (Position Closed) | View |
| 2021-02-16 2:22 pm Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |